Medifast (MED) Tops Q2 EPS by 11c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $11.02 -0.18%
EPS Growth %: -295.5%
Financial Fact:
Provision for income taxes: 2.95M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -295.5%
Financial Fact:
Provision for income taxes: 2.95M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q2 EPS of $0.63, $0.11 better than the analyst estimate of $0.52. Revenue for the quarter came in at $75.7 million versus the consensus estimate of $71.96 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- AXT appoints Tracy Liu to its board of directors
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
